SCHEME 3. Synthesis and Functionalization of
Tr-Protected Aziridine 21a
cm-1) 3057 (w), 1597 (s), 1490 (s), 1480 (s) 1365 (m); HRMS
(EI) m/z (M+) calcd for C29H27NO3S 469.1712, found 469.1708.
Representative Procedure for Cu-Catalyzed Grignard Sub-
stitution: (R)-2-Pentyl-1-tritylaziridine (10). To a solution of 2
(0.1 g, 0.213 mmol, 1 equiv) and CuBr‚DMS (11 mg, 0.05 mmol,
0.25 equiv) in THF (1.3 mL) was added freshly prepared butyl-
magnesium bromide solution in THF (titrated to 0.55 M, 0.77 mL,
0.426 mmol, 2 equiv) at -78 °C. The resulting solution was stirred
at -78 °C for 15 min and allowed to warm to rt overnight. The
reaction mixture was quenched with water, poured onto brine, and
extracted with ethyl acetate. The combined organic extracts were
dried over MgSO4 and concentrated in vacuo. Flash chromatography
(5:1, petroleum ether:EtOAc) provided 10 as a clear oil (65 mg,
86%). [R]22D -19.4 (c 1.00, CHCl3). 1H NMR (250 MHz, CDCl3)
δ 0.84 (3H, t, J ) 6.5 Hz), 1.02 (1H, d, J ) 6.0 Hz), 1.10-1.25
(8H, m), 1.55 (1H, d, J ) 3.5 Hz), 1.87 (1H, m), 7.19-7.51 (15H,
m); 13C NMR (62.9 MHz, CDCl3) δ 14.0, 22.6, 26.6, 26.7, 31.8,
a Reagents and conditions: (a) (i) Swern. (ii) MeLi, THF, -78 °C to rt,
1 h; 87% over two steps. (b) TsCl, Et3N, cat. DMAP, 4 d; 81%. (c) NaN3,
DMF, 60 °C, 16 h; 72%. (d) (i) PhMgBr, 25% CuBr‚DMS, THF, -78 °C
to rt, 16 h. (ii) TFA, CHCl3, MeOH (3:1), -78 °C to rt, 4 h. (iii) Et3N,
TsCl, 16 h; 54% over three steps.
32.8, 33.0, 72.1, 126.5, 127.3, 129.6, 145.0; FTIR (film, υmax cm-1
)
3056 (w), 2927 (w), 1596 (s), 1489 (s), 1447 (m); HRMS (EI) m/z
(M+) calcd for C26H29N 355.2300, found 355.2288.
In an effort to develop the chemistry to include more heavily
substituted systems, we investigated the synthesis and alkylation
of a secondary tosylate analogue 25. As outlined in Scheme 3,
oxidation of 1 followed by addition of MeLi provided a 4:1
mixture of diastereomeric alcohols 24 that were tosylated in
good yield. A diastereomerically enriched (20:1 dr) sample of
25 was generated by recrystallization from hexane/ethyl acetate.
Azide substitution of 25 took place in good yield and with clean
inversion to provide 26. Moreover, Cu-catalyzed substitution
with PhMgBr was also successful; however, the nonpolar nature
of the product resulted in inefficient chromatographic purifica-
tion. We therefore subjected the crude material to the one-pot
deprotection-protection protocol and were pleased to isolate
27 in 54% yield over the three steps.16
Synthesis of (S)-2-(Azidomethyl)-1-tritylaziridine (17). To a
solution of 2 (0.25 g, 0.532 mmol, 1 equiv) in DMF (1.8 mL) was
added sodium azide (0.17 g, 2.66 mmol, 5 equiv) at rt. The solution
was heated to 60 °C and left overnight. Upon cooling, diethyl ether
was added to the solution and the reaction was quenched with brine.
The organic extracts were washed with water, dried over MgSO4,
and concentrated in vacuo. Flash chromatography (5:1 petroleum
ether:EtOAc) provided 17 as a pale yellow oil (0.175 g, 97%). [R]23
D
1
-12.0 (c 1.67, CHCl3). H NMR (250 MHz, CDCl3) δ 1.17 (1H,
d, J ) 6.0 Hz), 1.48 (1H, m), 1.82 (1H, d, J ) 3.0 Hz), 3.48 (2H,
d, J ) 5.0 Hz), 7.16-7.35 (9 H, m), 7.52 (6 H, d, J ) 7.0 Hz); 13
C
NMR (62.9 MHz, CDCl3) δ 25.5, 31.6, 53.6, 74.0, 126.8, 127.6,
129.4, 144.2; FTIR (film, υmax cm-1) 3057 (w) 2923 (m), 2852
(m), 2096 (s), 1596 (m), 1487 (m); HRMS (EI) m/z (M+) calcd for
C22H20N4 340.1688, found 340.1685.
In summary, we report a simple and practical route to a range
of enantioenriched aziridines through the Cu-catalyzed substitu-
tion of a readily available aziridinylmethyl tosylate 2. Moreover,
we have developed a one-pot procedure for the conversion of
the product N-trityl aziridines to a range of more activated
substrates that could be further employed as electrophilic
reagents.
Representative Procedure for the Deprotection and Repro-
tection of Tritylaziridines. (R)-2-Benzyl-1-tosylaziridine (20).15
To a solution of 13 (0.1 g, 0.27 mmol, 1 equiv) in a mixture of
chloroform (1.5 mL) and methanol (0.5 mL) was added trifluoro-
acetic acid (0.616 mL, 7.99 mmol, 30 equiv) at -78 °C. The
solution was stirred at -78 °C for 15 min then allowed to warm to
0 °C for 4 h upon which triethylamine (1.23 mL, 8.79 mmol, 33
equiv) was added to the solution at 0 °C. After 10 min, a solution
of tosyl chloride (61 mg, 0.32 mmol, 1.2 equiv) in chloroform (0.5
mL) was added via cannula and the mixture was stirred overnight
at 0 °C. NaHCO3 solution was added and the solution was extracted
with chloroform. The organic extracts were dried over MgSO4 and
concentrated in vacuo and the product purified by flash chroma-
tography (5:1 petroleum ether:EtOAc) to provide 20 as a colorless
solid (63 mg, 81%). Mp 92-94 °C. [R]22D -20.0 (c 1.00, CHCl3).
1H NMR (250 MHz, CDCl3) δ 2.15 (1H, d, J ) 4.5 Hz), 2.42 (3H,
s), 2.67 (1H, dd, J ) 15.0, 7.0 Hz) 2.72 (1H, d, J ) 7.0 Hz), 2.80
(1H, d, J ) 15.0, 5.0 Hz), 2.89-3.00 (1H, m), 7.01-7.18 (5H, m),
7.20 (2H, d, J ) 8.0 Hz), 7.67 (2H, d, J ) 8.0 Hz); 13C NMR
(62.9 MHz, CDCl3) δ 21.6, 32.8, 37.5, 41.2, 126.5, 127.9, 128.4,
128.7, 129.6, 134.9, 137.0, 144.3.
Experimental Section
(S)-(1-Tritylaziridin-2-yl)methyl 4-Methylbenzenesulfonate
(2). To a solution of (S)-(1-tritylaziridin-2-yl)-methanol (1, 1.94 g,
6.15 mmol, 1 equiv)11b in CH2Cl2 (31 mL) were added triethylamine
(0.94 mL, 6.77 mmol, 1.1 equiv), tosyl chloride (1.30 g, 6.77 mmol,
1.1 equiv), and DMAP (0.08 g, 0.62 mmol, 0.1 equiv) at 0 °C.
The solution was left to warm to rt overnight, washed with NaHCO3,
and extracted with CH2Cl2. The organic extracts were dried over
MgSO4 and concentrated in vacuo to provide 2 as a pale yellow
solid (2.65 g, 92%). Mp 82-84 °C. [R]23D -33.0 (c 1.00, CHCl3).
1H NMR (250 MHz, CDCl3) δ 1.04 (1H, d, J ) 6.0 Hz), 1.43 (1H,
m), 1.62 (1H, d, J ) 2.5 Hz), 2.39 (3H, s), 4.06 (1H, dd, J ) 10.5,
5.5 Hz), 4.32 (1H, dd, J ) 10.5, 5.5 Hz), 7.14-7.68 (19H, m); 13
C
NMR (62.9 MHz, CDCl3) δ 21.1, 25.5, 30.5, 72.5, 73.8, 126.8,
Acknowledgment. We are grateful to the EPSRC and Eli
Lilly and Company Ltd for financial support.
127.5, 127.9, 129.3, 129.9, 133.2, 144.0, 144.7; FTIR (film, υmax
(16) The stereochemistry of compounds 25, 26, and 27 has been
elucidated by X-ray crystallography. CCDC 659299, CCDC 659300, and
CCDC 661089 contain the supplementary crystallographic data for 25, 26,
and 27, respectively. This data can be obtained free of charge via
lographic Data Centre, 12 Union Road, Cambridge, CB2 1EZ, UK; fax
(+44) 1223-336-033; or request@ccdc.cam.ac.uk).
Supporting Information Available: Experimental procedures,
1H /13C NMR spectra for selected compounds, and X-ray data for
compounds 25, 26, and 27. This material is available free of charge
JO7023637
1130 J. Org. Chem., Vol. 73, No. 3, 2008